Replies to post #535682 on NorthWest Biotherapeutics Inc (NWBO)

[jdheart101]

LP isn’t letting this go cheap 40 to 60 billion in my opinion

[muee88]

I keep hearing there are 1.5B shares outstanding. TD Ameritrade indicates there are 1.05B share outstanding. Which is correct? Someone mentioned it’s 1.5B including class C shares. Someone else mentioned the class C shares don’t need to have a payout?

[FeMike]

It would be an absolute disgrace and embarrassment if MHRA approves this but not the FDA. You would have 80% of Americans with GBM flying to London every year to try and get this treatment, and the Swanston facility will likely still be at capacity.

First off, you clearly have no idea how approvals or insurance works. You can’t just fly to the place where it’s approved and have your American insurance cover it.

Second, how are y’all seriously still not realizing that I’m not talking about buyout value? I’m talking about the market value of NWBO in 3-6 months assuming MHRA approves DCVax-L. Nothing else. I’m not talking about any potential buyout.

Wow y’all are defensive.